Australia's Noxopharm hits three-month low on discounted placement
BUZZ-Australia's Noxopharm hits three-month low on discounted placement ** Noxopharm Ltd NOX.AX shares fall as much as 2.0% to A$0.048, their lowest level since July 15
** The biotech firm receives commitments to raise A$1.5 million ($1.05 million) via placement at A$0.042 per share
** Issue price represents a 14.3% discount to the stock's last closing price on October 26
** Co says proceeds will fund its investigational new drug-enabling activities, preclinical programs and working capital
** YTD, stock down 48.4%, including the session's moves
($1 = 1.4225 Australian dollars)
(Reporting by Paridhi Minda in Bengaluru)
Recent news on Noxopharm
See all newsAustralia's Noxopharm hits three-month low on discounted placement
Brief: Noxopharm Receives Commitments For Placement
Brief: Noxopharm Requests Trading Halt Pending Material Capital Raising Announcement
Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential